|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172.60 USD | +0.06% |
|
-4.26% | +13.51% |
| 09:19am | Morgan Stanley Adjusts Biogen Price Target to $156 From $149, Maintains Equalweight Rating | MT |
| 06:34am | Alzheimer's drug hunt learns from cancer fight's multi-target playbook | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | +0.62% | -4.26% | +13.51% | +11.75% | -29.22% | 25.31B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
